Status:

COMPLETED

Cognitive Enhancement on Working Memory in Patients With Schizophrenia

Lead Sponsor:

Taipei Medical University Shuang Ho Hospital

Conditions:

Memory Deficits

Schizophrenia

Eligibility:

All Genders

20-55 years

Phase:

NA

Brief Summary

The investigators plan to investigate the effect of enhancement on working memory (WM) in patients of chronic schizophrenia and determine the predictive factors of effective treatment.

Detailed Description

Schizophrenia is a chronic and disabling disease with a prevalence of 0.5%\~1.5% in the general population. It's estimated 98% of patients with schizophrenia exhibit variable degrees of cognitive defi...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Inform consent acquired
  • Age 20 to 50
  • Right-handed
  • Patients with schizophrenia diagnosed according to DSM-5 criteria
  • Exclusion criteria
  • Participants who are pregnant or breastfeeding
  • Participants who have metal implants
  • Participants who have alcohol/substance use disorder or received electro-convulsive therapy within the past 6 months.
  • Participants who have history of head injury with loss of consciousness
  • Participants who have history of brain lesions, infection, or epilepsy
  • Skin lesions on the electrodes placed
  • Cancer patients
  • Patients with high fever
  • Patients with significant sensory loss

Exclusion

    Key Trial Info

    Start Date :

    May 1 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 30 2021

    Estimated Enrollment :

    28 Patients enrolled

    Trial Details

    Trial ID

    NCT03872310

    Start Date

    May 1 2019

    End Date

    August 30 2021

    Last Update

    August 11 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Shuang-Ho Hospital

    Taipei, Taiwan, 235